Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Some dibenzo compounds might help treat cancer with fewer side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The endocannabinoid system affects oil production and inflammation in skin cells.

CBD can either reduce inflammation and not affect hair growth at low levels or inhibit hair growth at high levels.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Certain Dibenzo derivatives may help treat prostate cancer.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Calancardin B may help reduce inflammation in immune cells.

Compound 7p shows strong potential as an anticancer agent.

Compound 15a was effective in inhibiting 5α-reductase.

Researchers made two new compounds that could be used for medicine.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.